Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Dermatology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Dermatitis, Atopic Clinical Trials

A listing of Dermatitis, Atopic medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (149) clinical trials

Now enrolling for an eczema research study for adults in San Antonio, TX. For more information contact: Clinical Trials of Texas, Inc. 210-949-0122.

Phase N/A

The purpose of this study is to evaluate the efficacy and safety of baricitinib in adult participants with moderate to severe atopic dermatitis.

Phase

Eczema holding you back? If you are 18 years or older and struggle with eczema, you may qualify for a new clinical research study. The study is for an investigational eczema medication that is delivered as an injection at the doctor’s office.

Phase N/A

A randomised, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy and safety of an injectable medication, tralokinumab, in combination with topical corticosteroids in subjects with moderate-to-severe atopic dermatitis who are candidates for systemic therapy.

Phase

Now enrolling ages 18 and older for moderate to severe atopic dermatitis.

Phase N/A

This is a double-blind, randomized, placebo-controlled study to assess the efficacy, safety, and tolerability of serlopitant for the treatment of pruritus (itching) in adults with prurigo nodularis (abbreviated as PN, a skin condition with multiple very itchy, solid skin bumps that develop due to scratching).  All enrolled subjects will receive ...

Phase

This study will be evaluating the efficacy, tolerability and safety of lebrikizumab compared to placebo in subjects with moderate to severe atopic dermatitis. This is a phase 2b, randomized, placebo-controlled, double-blind study in which subjects will be randomized to receive either lebrikizumab 125mg every 4 weeks, 250mg every 2 weeks, ...

Phase

This registry aims to characterize the patients who receive DUPIXENT for atopic dermatitis (AD) in a real world setting, with respect to their medical history, socio-demographic and disease characteristics, and prior and concomitant treatments of AD.

Phase

Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticosteroids (TCS) in Participants 6 to <12 Years With Severe Atopic Dermatitis (AD)

The main objective of the trial is to demonstrate the efficacy of dupilumab administered concomitantly with topical corticosteroids (TCS) in participants 6 years to <12 years of age with severe atopic dermatitis (AD). The secondary objective is to assess the safety of dupilumab administered concomitantly with TCS in patients 6 ...

Phase

Safety Pharmacokinetics and Efficacy of Dupilumab in Patients 6 Months to <6 Years With Severe Atopic Dermatitis (Liberty AD PRESCHOOL)

Part A (open-label, single-ascending-dose, sequential cohort phase 2 study): Primary objective is to characterize the safety and PK of dupilumab administered as a single dose in pediatric patients, 6 months to less than 6 years of age, with severe AD. Secondary objective is to evaluate the efficacy and immunogenicity of ...

Phase